[18F]FDG PET is currently the most commonly used functional imaging method for the in vivo investigation of regional brain metabolism in clinical practice. PET/CT scanners are widely available in Europe, in the US, in Australia, and most of the rest of the world [1] and the clinical role of [18F]FDG brain PET can be regarded as established for a number of diagnostic challenges in Neurology and Psychiatry [2]. In particular, [18F]FDG PET plays a major role in the early and differential diagnosis of neurodegenerative dementias and Parkinsonian syndromes by showing disease-specific patterns of hypometabolism [3].

The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET. the autoimmune encephalitis / Morbelli, S.; Arbizu, J.; Booij, J.; Chen, M. -K.; Chetelat, G.; Cross, D. J.; Djekidel, M.; Drzezga, A.; Ekmekcioglu, O.; Garibotto, V.; Hesse, S.; Ishii, K.; Saraf, L. J.; Lammertsma, A. A.; Law, I.; Mathews, D.; Minoshima, S.; Mosci, K.; Pagani, M.; Pappata, S.; Silverman, D. H.; Signore, A.; Van De Giessen, E.; Villemagne, V.; Barthel, H.. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7070. - 44:3(2017), pp. 353-357. [10.1007/s00259-016-3589-9]

The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET. the autoimmune encephalitis

Law I.;Signore A.;
2017

Abstract

[18F]FDG PET is currently the most commonly used functional imaging method for the in vivo investigation of regional brain metabolism in clinical practice. PET/CT scanners are widely available in Europe, in the US, in Australia, and most of the rest of the world [1] and the clinical role of [18F]FDG brain PET can be regarded as established for a number of diagnostic challenges in Neurology and Psychiatry [2]. In particular, [18F]FDG PET plays a major role in the early and differential diagnosis of neurodegenerative dementias and Parkinsonian syndromes by showing disease-specific patterns of hypometabolism [3].
2017
encephalitis; hashimoto disease; humans; positron-emission tomography; reference standards; fluorodeoxyglucose f18; radiopharmaceuticals
01 Pubblicazione su rivista::01a Articolo in rivista
The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET. the autoimmune encephalitis / Morbelli, S.; Arbizu, J.; Booij, J.; Chen, M. -K.; Chetelat, G.; Cross, D. J.; Djekidel, M.; Drzezga, A.; Ekmekcioglu, O.; Garibotto, V.; Hesse, S.; Ishii, K.; Saraf, L. J.; Lammertsma, A. A.; Law, I.; Mathews, D.; Minoshima, S.; Mosci, K.; Pagani, M.; Pappata, S.; Silverman, D. H.; Signore, A.; Van De Giessen, E.; Villemagne, V.; Barthel, H.. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7070. - 44:3(2017), pp. 353-357. [10.1007/s00259-016-3589-9]
File allegati a questo prodotto
File Dimensione Formato  
Morbelli_need-of-standardization_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 265.89 kB
Formato Adobe PDF
265.89 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1413695
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 31
social impact